Bioresorbable polymer-coated thin strut sirolimus-eluting stent vs durable polymer-coated everolimus-eluting stent in daily clinical practice: Propensity matched one-year results from interventional cardiology network registry.
Paweł M GąsiorMarek GierlotkaKrzysztof Szczurek-KatanskiMarcin OsuchRoman GnotMichał HawranekMariusz GasiorLech PolonskiPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
In this multicenter registry, the BP-SES thin strut biodegradable polymer-coated sirolimus-eluting stent demonstrated comparable clinical outcomes at 1-year after implantation to the DP-EES. These data support the relative safety and efficacy of DP-SES in a broad range of patients undergoing percutaneous coronary intervention.
Keyphrases
- percutaneous coronary intervention
- patients undergoing
- clinical practice
- acute coronary syndrome
- drug delivery
- coronary artery disease
- acute myocardial infarction
- st segment elevation myocardial infarction
- physical activity
- st elevation myocardial infarction
- cardiac surgery
- electronic health record
- atrial fibrillation
- cross sectional
- coronary artery bypass grafting
- clinical trial
- heart failure
- antiplatelet therapy
- left ventricular
- data analysis
- acute kidney injury
- artificial intelligence